Intermolecular Inc (IMI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,596 | -2,262 | -3,411 | -814 | -127 |
| Depreciation Amortization | 1,910 | 1,090 | 4,717 | 3,514 | 2,693 |
| Accounts receivable | 1,408 | 898 | 2,646 | 2,666 | 4,074 |
| Accounts payable and accrued liabilities | -520 | -489 | -197 | -304 | -750 |
| Other Working Capital | -1,271 | -2,208 | 3,588 | 1,724 | 2,883 |
| Other Operating Activity | 49 | 56 | -1,405 | -1,738 | -2,842 |
| Operating Cash Flow | $-6,020 | $-2,915 | $5,938 | $5,048 | $5,931 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 398 | -1,491 | -2,587 | -3,817 | -7,357 |
| PPE Investments | -574 | -134 | -1,275 | -619 | -489 |
| Investing Cash Flow | $-176 | $-1,625 | $-3,862 | $-4,436 | $-7,846 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 5 | 5 | 185 | 187 | 172 |
| Financing Cash Flow | $5 | $5 | $185 | $187 | $172 |
| Beginning Cash Position | 8,351 | 8,351 | 6,090 | 6,090 | 6,090 |
| End Cash Position | 2,160 | 3,816 | 8,351 | 6,889 | 4,347 |
| Net Cash Flow | $-6,191 | $-4,535 | $2,261 | $799 | $-1,743 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,020 | -2,915 | 5,938 | 5,048 | 5,931 |
| Capital Expenditure | -574 | -134 | -1,287 | -620 | -489 |
| Free Cash Flow | -6,594 | -3,049 | 4,651 | 4,428 | 5,442 |